Triple
T1182959
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Committee for Herbal Medicinal Products |
E25179
|
entity |
| Predicate | replaced |
P101
|
FINISHED |
| Object |
Working Party on Herbal Medicinal Products
The Working Party on Herbal Medicinal Products was a European regulatory expert group responsible for evaluating and providing guidance on the quality, safety, and efficacy of herbal medicinal products before being succeeded by the Committee for Herbal Medicinal Products.
|
E25179
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Working Party on Herbal Medicinal Products | Statement: [Committee for Herbal Medicinal Products, replaced, Working Party on Herbal Medicinal Products]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Working Party on Herbal Medicinal Products Context triple: [Committee for Herbal Medicinal Products, replaced, Working Party on Herbal Medicinal Products]
-
A.
Committee for Herbal Medicinal Products
The Committee for Herbal Medicinal Products is a scientific body within the European Medicines Agency that evaluates and provides guidance on the safety and efficacy of herbal medicines in the European Union.
-
B.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
-
C.
Committee for Medicinal Products for Veterinary Use
The Committee for Medicinal Products for Veterinary Use is the European Medicines Agency’s scientific committee responsible for evaluating and providing opinions on veterinary medicines in the European Union.
-
D.
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
-
E.
Management Board of the European Medicines Agency
The Management Board of the European Medicines Agency is the governing body that oversees the agency’s strategy, budget, and overall operations in regulating medicines within the European Union.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Working Party on Herbal Medicinal Products Triple: [Committee for Herbal Medicinal Products, replaced, Working Party on Herbal Medicinal Products]
Generated description
The Working Party on Herbal Medicinal Products was a European regulatory expert group responsible for evaluating and providing guidance on the quality, safety, and efficacy of herbal medicinal products before being succeeded by the Committee for Herbal Medicinal Products.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Working Party on Herbal Medicinal Products Target entity description: The Working Party on Herbal Medicinal Products was a European regulatory expert group responsible for evaluating and providing guidance on the quality, safety, and efficacy of herbal medicinal products before being succeeded by the Committee for Herbal Medicinal Products.
-
A.
Committee for Herbal Medicinal Products
chosen
The Committee for Herbal Medicinal Products is a scientific body within the European Medicines Agency that evaluates and provides guidance on the safety and efficacy of herbal medicines in the European Union.
-
B.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
-
C.
Committee for Medicinal Products for Veterinary Use
The Committee for Medicinal Products for Veterinary Use is the European Medicines Agency’s scientific committee responsible for evaluating and providing opinions on veterinary medicines in the European Union.
-
D.
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
-
E.
Management Board of the European Medicines Agency
The Management Board of the European Medicines Agency is the governing body that oversees the agency’s strategy, budget, and overall operations in regulating medicines within the European Union.
- F. None of above.
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a494267b4c819088c97a59182bf56a |
completed | March 1, 2026, 7:31 p.m. |
| NER | Named-entity recognition | batch_69a4bd35fb888190adf1e5d0615fa725 |
completed | March 1, 2026, 10:27 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69ac6f21547c81909cf23c454436e839 |
completed | March 7, 2026, 6:32 p.m. |
| NEDg | Description generation | batch_69ac6fc5442c8190a5d824881f05d468 |
completed | March 7, 2026, 6:34 p.m. |
| NED2 | Entity disambiguation (via description) | batch_69ac7026dda48190a72f671dba9ac17b |
completed | March 7, 2026, 6:36 p.m. |
Created at: March 1, 2026, 7:45 p.m.